Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Riesterer O, Pruschy M, Bender S, Sharma A, Bogowicz M, Tanadini-Lang S, Stieb S, Bertogg K, Weber S, Ikenberg K, Huber G, Schmid S, Bredell M, Veit-Haibach P, Rordorf T, Held U, Glanzmann C, Studer G.
Riesterer O, et al. Among authors: bredell m.
Radiother Oncol. 2020 Sep;150:62-69. doi: 10.1016/j.radonc.2020.06.011. Epub 2020 Jun 12.
Radiother Oncol. 2020.
PMID: 32540337
Clinical Trial.